Cost-benefit, cost-effectiveness research of drug abuse prevention : implications for programming and policy / editors, William J. Bukoski, Richard I. Evans.
Imprint
Rockville, Md. : U.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Division of Epidemiology and Prevention Research, 1998.
"Based on the papers from a technical review ... held on July 28-29, 1994."--p. ii.
Bibliography
Includes bibliographical references.
Contents
Impact of substance abuse on federal spending -- Historical perspective on effective prevention -- School-based approaches to drug abuse prevention: evidence for effectiveness and suggestions for determining cost-effectiveness -- Effectiveness of prevention interventions with youth at high risk of drug abuse -- Costs, benefits, and cost-effectiveness of comprehensive drug abuse prevention -- Overview of methods: cost-effectiveness, cost-benefits, and cost-offsets of prevention -- Analytic issues for estimating the benefits and costs of substance abuse prevention -- Benefits and costs of a family-focused methadone treatment and drug abuse prevention program: preliminary findings -- Issues and methods in evaluating costs, benefits, and cost-effectiveness of drug abuse prevention programs for high-risk youth -- Implications for prevention policy: a commentary.
